正在加载视频...

视频加载失败

加载此视频时出现问题。这可能是由于临时网络问题，或视频可能不可用。

FRAmework-01 | Now Enrolling A Ph3 trial evaluating a FRα-targeting ADC in patients with ovarian cancer. Key details: - Enrolling PSOC and PROC - All FRα expression levels - Allows prior mirvetuximab 👇 Click below for trial and enrollment details

Lilly Oncology Medical

6,550 subscribers

2,675,562 次观看 • 5 个月前 •via X (Twitter)

健康养生新闻政治科学技术

Anya Rossi• Live Now

Private livecam show

0 条评论

暂无评论

原始帖子的评论将显示在这里

相关视频

Shocking results, hope restored for cancer patients. Cancer vanished in 100% of the patients, after 6 months trial with a drug, dostarlimab, with no significant side effects, first time in history of cancer. Colorectal/rectal cancer the 5th commonest cancer in Africa, and usually by the time its diagnosed it would have spread throughout the body giving low survival rates with the traditional treatment.

Shocking results, hope restored for cancer patients. Cancer vanished in 100% of the patients, after 6 months trial with a drug, dostarlimab, with no significant side effects, first time in history of cancer. Colorectal/rectal cancer the 5th commonest cancer in Africa, and usually by the time its diagnosed it would have spread throughout the body giving low survival rates with the traditional treatment.

Dr. Misheck Ruwende

107,404 次观看 • 3 年前

IT’S ALL A BLUR TOUR with Drizzy & Saint Laurent Don Dates now live on click the link in bio for more information and details for your location.

IT’S ALL A BLUR TOUR with Drizzy & Saint Laurent Don Dates now live on click the link in bio for more information and details for your location.

OVO Sound

2,951,591 次观看 • 3 年前

Grok Imagine 1.5 is now live on TapNow. Turn one image into a video with dialogue, sound effects, and ambience generated in sync. Click the link below for more details.

Grok Imagine 1.5 is now live on TapNow. Turn one image into a video with dialogue, sound effects, and ambience generated in sync. Click the link below for more details.

TapNow

14,962 次观看 • 21 天前

We are thrilled to share positive topline data from our ELEVATE IPF Phase 2b trial evaluating deupirfenidone (LYT-100) for the treatment of idiopathic pulmonary fibrosis (#IPF), a progressive and fatal lung disease. Our trial met the primary and key secondary endpoints, with deupirfenidone demonstrating the potential to serve as a new standard of care. Over 26 weeks, the highest dose of deupirfenidone studied was generally well-tolerated and reduced lung function decline to levels that approach natural lung function decline in healthy adults over sixty—a first for any investigational or approved treatment for IPF. We’re incredibly excited for what deupirfenidone could offer the IPF community, which urgently needs new treatment options with better efficacy that don’t compromise on tolerability. A heartfelt thank you to everyone who participated in the ELEVATE IPF trial, including patients, caregivers, clinical trial sites, and advocacy groups. Your courage, dedication and expertise make progress possible, and we are grateful for your trust and partnership. Read more in today’s press release:

We are thrilled to share positive topline data from our ELEVATE IPF Phase 2b trial evaluating deupirfenidone (LYT-100) for the treatment of idiopathic pulmonary fibrosis (#IPF), a progressive and fatal lung disease. Our trial met the primary and key secondary endpoints, with deupirfenidone demonstrating the potential to serve as a new standard of care. Over 26 weeks, the highest dose of deupirfenidone studied was generally well-tolerated and reduced lung function decline to levels that approach natural lung function decline in healthy adults over sixty—a first for any investigational or approved treatment for IPF. We’re incredibly excited for what deupirfenidone could offer the IPF community, which urgently needs new treatment options with better efficacy that don’t compromise on tolerability. A heartfelt thank you to everyone who participated in the ELEVATE IPF trial, including patients, caregivers, clinical trial sites, and advocacy groups. Your courage, dedication and expertise make progress possible, and we are grateful for your trust and partnership. Read more in today’s press release:

PureTech

10,892 次观看 • 1 年前

I met with a constituent who was participating in a cancer treatment trial that DOGE deemed unnecessary. I was proud to help advocate for Richard so he could resume his treatment. Cancer patients are not waste, fraud, and abuse. They're our loved ones who deserve care.

I met with a constituent who was participating in a cancer treatment trial that DOGE deemed unnecessary. I was proud to help advocate for Richard so he could resume his treatment. Cancer patients are not waste, fraud, and abuse. They're our loved ones who deserve care.

Senator Reverend Raphael Warnock

197,906 次观看 • 10 个月前

It’s been weirdly quiet over Two Tier Keir’s Ukranian arsonist scandal. But now two of the young Ukranian models have put in a Not Guilty plea. That’s awkward for Keir as unless something changes it means it will go to trial AND all the details could come out as the defence will mount a case and call witnesses. The next hearing is at the end of November and trial scheduled for end of April. What’s the betting something mysterious stops the trial..

It’s been weirdly quiet over Two Tier Keir’s Ukranian arsonist scandal. But now two of the young Ukranian models have put in a Not Guilty plea. That’s awkward for Keir as unless something changes it means it will go to trial AND all the details could come out as the defence will mount a case and call witnesses. The next hearing is at the end of November and trial scheduled for end of April. What’s the betting something mysterious stops the trial..

JohnHann0404🇬🇧🏴󠁧󠁢󠁥󠁮󠁧󠁿

226,564 次观看 • 9 个月前

With 2025 around the corner, Vagabond is wrapping up 3 years of continuous building and gearing up for a blast in the year ahead! 🎇 💠 Key milestone: Migration of VAGA to SYNNQ Get all the details in our newly published FAQ below! 👇

With 2025 around the corner, Vagabond is wrapping up 3 years of continuous building and gearing up for a blast in the year ahead! 🎇 💠 Key milestone: Migration of VAGA to SYNNQ Get all the details in our newly published FAQ below! 👇

Vagabond

26,992 次观看 • 1 年前

I asked nano banana to put me in there with my favorite toys and now I’m basically a Playmobil figure... all the details on how I made this video on leonardo, below 👇

I asked nano banana to put me in there with my favorite toys and now I’m basically a Playmobil figure... all the details on how I made this video on leonardo, below 👇

TechHalla

43,627 次观看 • 10 个月前

The assassination of Shireen was a trial run for the systematic targeting of hundreds of journalists and media workers in Gaza, the West Bank, and now Lebanon, and it was the Biden administration that gave the green light for all of it.

The assassination of Shireen was a trial run for the systematic targeting of hundreds of journalists and media workers in Gaza, the West Bank, and now Lebanon, and it was the Biden administration that gave the green light for all of it.

gato fumante

110,332 次观看 • 2 个月前

Aortic dissection is a life-threatening emergency where every minute matters. In this interview, Dr. Firas Mussa and I discuss the key signs and symptoms clinicians should recognize, why early diagnosis is so critical, and how the IMPROVE-AD trial aims to advance the care of patients with acute aortic dissection. For more information on the IMPROVE-AD trial, please email improve-ad@duke.edu

Aortic dissection is a life-threatening emergency where every minute matters. In this interview, Dr. Firas Mussa and I discuss the key signs and symptoms clinicians should recognize, why early diagnosis is so critical, and how the IMPROVE-AD trial aims to advance the care of patients with acute aortic dissection. For more information on the IMPROVE-AD trial, please email [email protected]

C. Michael Gibson MD

15,360 次观看 • 23 天前

A tough call 📱 Season Ticket holders and Well Society members are now able to vote for their 2025/26 Goal of the Season. Please click the link below for all the details on how to vote. 👉

A tough call 📱 Season Ticket holders and Well Society members are now able to vote for their 2025/26 Goal of the Season. Please click the link below for all the details on how to vote. 👉

Motherwell FC

11,216 次观看 • 4 个月前

New research suggests Vitamin D isn't just a supplement; it may be a critical key that unlocks cancer treatment efficacy. Oncologist Dr. Angus Dalgleish reveals a stunning finding: In pancreatic cancer trials, the only patients who responded to chemotherapy were those with normal Vitamin D levels. The implication is direct: A Vitamin D deficiency may render powerful treatments like chemotherapy and immunotherapy ineffective. Correcting levels beforehand could be the simple, non-negotiable step that allows these therapies to work. This isn't just an add-on; it's a potential prerequisite for treatment success.

New research suggests Vitamin D isn't just a supplement; it may be a critical key that unlocks cancer treatment efficacy. Oncologist Dr. Angus Dalgleish reveals a stunning finding: In pancreatic cancer trials, the only patients who responded to chemotherapy were those with normal Vitamin D levels. The implication is direct: A Vitamin D deficiency may render powerful treatments like chemotherapy and immunotherapy ineffective. Correcting levels beforehand could be the simple, non-negotiable step that allows these therapies to work. This isn't just an add-on; it's a potential prerequisite for treatment success.

Camus

43,750 次观看 • 8 个月前

VIDEO - DOG LEFT ABANDONED IN GEORGINA PARK Investigators looking for a person who left a Cane Corso tied to a pole in the area of Lake Dr South/Robert St. Dog was not injured and not in distress, now in care of Georgina Animal Shelter and Adoption. Click below for more details:

VIDEO - DOG LEFT ABANDONED IN GEORGINA PARK Investigators looking for a person who left a Cane Corso tied to a pole in the area of Lake Dr South/Robert St. Dog was not injured and not in distress, now in care of Georgina Animal Shelter and Adoption. Click below for more details:

York Regional Police

49,399 次观看 • 1 年前

A blood cancer drug has shown promise in killing ‘silent’ #HIV cells and delaying reinfections, in a significant pre-clinical discovery that could lead to a future cure for the disease. The WEHI-Doherty Institute findings are now being translated into a clinical trial Watch👇 🧵1/2

A blood cancer drug has shown promise in killing ‘silent’ #HIV cells and delaying reinfections, in a significant pre-clinical discovery that could lead to a future cure for the disease. The WEHI-Doherty Institute findings are now being translated into a clinical trial Watch👇 🧵1/2

WEHI (Walter and Eliza Hall Institute)

12,079 次观看 • 2 年前

🌧️ Ready for a change? After a dry spell, low pressure is moving in - bringing rain, wind, and a soggy Sunday for many. ☁️ Find out all the details in our weekend forecast with Alex👇

🌧️ Ready for a change? After a dry spell, low pressure is moving in - bringing rain, wind, and a soggy Sunday for many. ☁️ Find out all the details in our weekend forecast with Alex👇

Met Office

16,103 次观看 • 10 个月前

Ketogenic diets in the ICU? The research is beginning to explore it. In a randomized controlled trial of 40 patients with sepsis, investigators tested a medically supervised ketogenic diet during critical illness. All patients in the ketogenic group achieved stable nutritional ketosis, with no serious adverse events attributed to the intervention. After day four, none of the ketogenic patients required insulin — compared to 35–60% of patients in the control group on any given day. The ketogenic group also experienced: • More ventilator-free days • More vasopressor-free days • More dialysis-free days • More ICU-free days Researchers observed signals consistent with reduced immune dysregulation and lower inflammatory signaling — a meaningful finding in a condition defined by metabolic chaos and systemic inflammation. This was a small, early-phase trial. It does not establish standard of care. But it adds to a growing body of evidence that metabolic therapy may have applications beyond chronic disease — including critical care. Check out the link below with details on how to access 150+ research summaries on metabolic health and therapy in our new Ketogenic Metabolic Therapy eBook!

Ketogenic diets in the ICU? The research is beginning to explore it. In a randomized controlled trial of 40 patients with sepsis, investigators tested a medically supervised ketogenic diet during critical illness. All patients in the ketogenic group achieved stable nutritional ketosis, with no serious adverse events attributed to the intervention. After day four, none of the ketogenic patients required insulin — compared to 35–60% of patients in the control group on any given day. The ketogenic group also experienced: • More ventilator-free days • More vasopressor-free days • More dialysis-free days • More ICU-free days Researchers observed signals consistent with reduced immune dysregulation and lower inflammatory signaling — a meaningful finding in a condition defined by metabolic chaos and systemic inflammation. This was a small, early-phase trial. It does not establish standard of care. But it adds to a growing body of evidence that metabolic therapy may have applications beyond chronic disease — including critical care. Check out the link below with details on how to access 150+ research summaries on metabolic health and therapy in our new Ketogenic Metabolic Therapy eBook!

Metabolic Health Summit

41,772 次观看 • 5 个月前

Welcome to Seal Generated Content 🦭🏝️ A special contest for the most active community in Nifty, , hosted by wale.moca 🐳 . 3D artists, now is your time to create Seal themed art and get rewarded with big NFT prizes! Details below 👇

Welcome to Seal Generated Content 🦭🏝️ A special contest for the most active community in Nifty, , hosted by wale.moca 🐳 . 3D artists, now is your time to create Seal themed art and get rewarded with big NFT prizes! Details below 👇

Nifty Island 🏝

221,376 次观看 • 2 年前

In patients with early septic shock, the ANDROMEDA‑SHOCK‑2 randomized clinical trial evaluated a personalized hemodynamic resuscitation protocol targeting normalization of capillary refill time. Compared with usual care, this strategy was superior for a hierarchical composite outcome of mortality, duration of vital support, and length of hospital stay at 28 days, with the overall benefit primarily attributable to a shorter duration of organ support. 🧵

In patients with early septic shock, the ANDROMEDA‑SHOCK‑2 randomized clinical trial evaluated a personalized hemodynamic resuscitation protocol targeting normalization of capillary refill time. Compared with usual care, this strategy was superior for a hierarchical composite outcome of mortality, duration of vital support, and length of hospital stay at 28 days, with the overall benefit primarily attributable to a shorter duration of organ support. 🧵

JAMA

13,331 次观看 • 3 个月前